Edwards Lifesciences (EW) Shares Outstanding (2009 - 2026)

Edwards Lifesciences has reported Shares Outstanding (Entity) for 18 years, with the latest figure at $576.6 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) fell 1.92% year-over-year to $576.6 million in Q2 2026; TTM through Jun 2026 was $576.6 million, a 1.92% decrease from a year earlier, with the FY2025 full-year figure at $580.7 million, down 1.34% from the prior year.
• Shares Outstanding (Entity) was $576.6 million for Q2 2026 at Edwards Lifesciences, roughly flat from $577.0 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $621.4 million in Q1 2022, with the low at $576.6 million in Q2 2026.
• Average Shares Outstanding (Entity) over 5 years is $597.9 million, with a median of $601.7 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) declined 0.06% in 2022, then dropped 2.75% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $608.3 million in 2022, then slipped by 1.18% to $601.1 million in 2023, then retreated by 2.08% to $588.6 million in 2024, then dropped by 1.34% to $580.7 million in 2025, then declined by 0.71% to $576.6 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $576.6 million (Q2 2026), $577.0 million (Q1 2026), and $580.7 million (Q4 2025), per Business Quant data.